{"id":343275,"date":"2025-08-22T11:43:34","date_gmt":"2025-08-22T11:43:34","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-biogen-2\/"},"modified":"2025-08-22T11:43:34","modified_gmt":"2025-08-22T11:43:34","slug":"how-to-buy-biogen-2","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/","title":{"rendered":"How to buy Biogen Inc. (BIIB) shares &#8211; Investment in Biogen Inc. (BIIB) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-343275","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Biogen Inc. (BIIB) Shares - Investment in Biogen Inc. (BIIB) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Biogen Inc. (BIIB) Shares - Investment in Biogen Inc. (BIIB) Stock"},"description":"Learn how to invest in Biogen Inc. (BIIB) stock with current price analysis, 2025 earnings insights, and step-by-step investment strategy for this innovative biotech company.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to invest in Biogen Inc. (BIIB) stock with current price analysis, 2025 earnings insights, and step-by-step investment strategy for this innovative biotech company."},"intro":"Thinking about investing in a company that's literally changing lives through medical innovation? Biogen Inc. stands at the forefront of neurological research, developing treatments for conditions that affect millions worldwide. With recent FDA approvals and a promising pipeline, this biotech giant offers both exciting growth potential and significant volatility - perfect for investors who understand the high-risk, high-reward nature of pharmaceutical stocks.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in a company that's literally changing lives through medical innovation? Biogen Inc. stands at the forefront of neurological research, developing treatments for conditions that affect millions worldwide. With recent FDA approvals and a promising pipeline, this biotech giant offers both exciting growth potential and significant volatility - perfect for investors who understand the high-risk, high-reward nature of pharmaceutical stocks."},"body_html":"<h2>\ud83d\udcc8 Biogen Stock: Current Price and Critical Dates<\/h2> <p>As of August 22, 2025, Biogen Inc. (BIIB) trades at <strong>$139.12<\/strong> on the NASDAQ exchange. Mark your calendar: <strong>October 29, 2025<\/strong> is absolutely critical - that's when Biogen releases its next quarterly earnings report.<\/p> <h3>Why Earnings Dates Matter for BIIB<\/h3> <p>Biotech stocks live and die by their clinical trial results and earnings reports. Looking at recent history:<\/p> <ul> <li><strong>July 31, 2025<\/strong>: Biogen reported EPS of $5.47, crushing expectations of $3.93 - the stock jumped 6% immediately<\/li> <li><strong>Previous quarter<\/strong>: Revenue grew 7.3% year-over-year to $2.65 billion<\/li> <li><strong>Historical pattern<\/strong>: Positive surprises typically boost prices by 5-10%, while misses can cause 15-20% drops<\/li> <\/ul> <p>The October report will be particularly important as investors watch Leqembi's commercial progress and how the company is managing declining sales from older MS drugs facing generic competition.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey: Rollercoaster with Recent Recovery<\/h2> <p>Biogen's stock has been on quite the ride over the past six months:<\/p> <table> <thead> <tr><th>Month<\/th><th>Price Range<\/th><th>Key Events<\/th><\/tr> <\/thead> <tbody> <tr><td>March 2025<\/td><td>$153-160<\/td><td>Starting strong but facing headwinds<\/td><\/tr> <tr><td>April 2025<\/td><td>$142-150<\/td><td>Generic competition concerns mounting<\/td><\/tr> <tr><td>May 2025<\/td><td>$135-145<\/td><td>Earnings beat but guidance cautious<\/td><\/tr> <tr><td>June 2025<\/td><td>$128-138<\/td><td>Clinical trial updates mixed<\/td><\/tr> <tr><td>July 2025<\/td><td>$124-132<\/td><td>Hit yearly lows around $124<\/td><\/tr> <tr><td>August 2025<\/td><td>$135-142<\/td><td>FDA approval boost +6%, current $139.12<\/td><\/tr> <\/tbody> <\/table> <p><strong>Why the volatility?<\/strong> Biogen operates in the notoriously unpredictable biotech sector where a single clinical trial result or FDA decision can move the stock 20-30% in a day. The recent recovery from July lows suggests investors are becoming more optimistic about the company's pipeline.<\/p> <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current analyst consensus and pipeline potential:<\/p> <p><strong>2025 Year-End<\/strong>: $160-180 range (15-30% upside from current)<\/p> <ul> <li>Driven by Leqembi adoption and pipeline progress<\/li> <li><strong>Verdict: BUY<\/strong> - current undervaluation presents opportunity<\/li> <\/ul> <p><strong>2026 Forecast<\/strong>: $190-220<\/p> <ul> <li>Full-year Leqembi contribution expected<\/li> <li>New pipeline candidates advancing<\/li> <\/ul> <p><strong>2028 Projection<\/strong>: $250-300<\/p> <ul> <li>Multiple new product launches anticipated<\/li> <li>Market leadership in neurology strengthened<\/li> <\/ul> <p><strong>2030 Vision<\/strong>: $350-450<\/p> <ul> <li>Potential breakthrough Alzheimer's treatments<\/li> <li>Expanded global market presence<\/li> <\/ul> <p>The wide range reflects the binary nature of biotech investing - success depends heavily on clinical trial outcomes and regulatory approvals.<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>Clinical trial failures<\/strong>: A single failed Phase 3 trial could drop the stock 30-40%<\/li> <li><strong>Regulatory hurdles<\/strong>: FDA rejections or delays can devastate share price<\/li> <li><strong>Generic competition<\/strong>: Older MS drugs continue facing pressure (<a href=\"https:\/\/www.nasdaq.com\/articles\/biogen-gears-report-q2-earnings-heres-what-expect\">Tysabri biosimilars expected Q4 2025<\/a>)<\/li> <li><strong>Pricing pressures<\/strong>: Healthcare reform could impact drug pricing<\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li><strong>FDA approval momentum<\/strong>: Recent 6% jump shows regulatory success<\/li> <li><strong>Strong financials<\/strong>: $2.27 billion free cash flow, 13.85% return on equity<\/li> <li><strong>Pipeline progress<\/strong>: Phase 3 studies advancing across multiple indications<\/li> <li><strong>Undervaluation<\/strong>: Trading at 24% discount to analyst targets according to <a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-biib\/biogen\/news\/evaluating-biogens-prospects-after-recent-fda-approval-boost\">Simply Wall St analysis<\/a><\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start small<\/strong>: Allocate no more than 5% of your portfolio to high-volatility biotech stocks<\/li> <li><strong>Dollar-cost average<\/strong>: Buy in increments rather than all at once to reduce timing risk<\/li> <li><strong>Set price alerts<\/strong>: Monitor around earnings dates (next: October 29, 2025)<\/li> <li><strong>Diversify<\/strong>: Balance BIIB with more stable healthcare stocks<\/li> <\/ol> <p>Humorous take: \"Trading Biogen is like being in a relationship with a brilliant scientist - incredibly rewarding when things go right, but prepare for some dramatic mood swings when experiments don't work out!\"<\/p> <h2>\u2705 How to Buy Biogen Inc. (BIIB) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NASDAQ-listed stocks and reasonable fees<\/td><\/tr> <tr><td>2<\/td><td>Open and fund your account<\/td><td>Start with an amount you're comfortable potentially losing<\/td><\/tr> <tr><td>3<\/td><td>Research BIIB thoroughly<\/td><td>Understand the risks and opportunities specific to biotech<\/td><\/tr> <tr><td>4<\/td><td>Place a limit order<\/td><td>Set your maximum purchase price to avoid overpaying<\/td><\/tr> <tr><td>5<\/td><td>Monitor and set alerts<\/td><td>Track earnings dates and clinical trial announcements<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2> <p>For those looking to start their investment journey, Pocket Option offers several advantages:<\/p> <ul> <li><strong>Minimum deposit: $5<\/strong> - Perfect for testing strategies with minimal risk<\/li> <li><strong>1-minute KYC verification<\/strong> - Upload any ID document and start trading immediately<\/li> <li><strong>100+ withdrawal methods<\/strong> - Flexibility with crypto, e-wallets, and traditional banking<\/li> <\/ul> <p>The platform's low barrier to entry makes it ideal for beginners who want to gain experience with biotech stocks like Biogen without committing large amounts of capital initially.<\/p> <h2>\ud83c\udf0d Biogen in 2025: Neuroscience Innovation Leader<\/h2> <p>Biogen remains a dominant force in neurological research, focusing on devastating conditions like Alzheimer's, multiple sclerosis, and ALS. The company's <a href=\"https:\/\/www.biogen.com\/company.html\">business model<\/a> balances groundbreaking science with commercial execution, investing over $10 billion in manufacturing capabilities since 1995.<\/p> <p>Recent developments include a <strong>$2 billion investment<\/strong> in their Research Triangle Park facility to expand antisense oligonucleotide capabilities and modernize manufacturing through AI and automation. The company also entered a strategic collaboration with City Therapeutics for RNA interference therapy development.<\/p> <p><strong>Interesting Fact for 2025<\/strong>: Biogen's manufacturing facilities now use artificial intelligence to predict equipment maintenance needs before failures occur, reducing downtime by 40% and ensuring continuous supply of critical medications to patients worldwide.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Biogen Stock: Current Price and Critical Dates<\/h2>\n<p>As of August 22, 2025, Biogen Inc. (BIIB) trades at <strong>$139.12<\/strong> on the NASDAQ exchange. Mark your calendar: <strong>October 29, 2025<\/strong> is absolutely critical &#8211; that&#8217;s when Biogen releases its next quarterly earnings report.<\/p>\n<h3>Why Earnings Dates Matter for BIIB<\/h3>\n<p>Biotech stocks live and die by their clinical trial results and earnings reports. Looking at recent history:<\/p>\n<ul>\n<li><strong>July 31, 2025<\/strong>: Biogen reported EPS of $5.47, crushing expectations of $3.93 &#8211; the stock jumped 6% immediately<\/li>\n<li><strong>Previous quarter<\/strong>: Revenue grew 7.3% year-over-year to $2.65 billion<\/li>\n<li><strong>Historical pattern<\/strong>: Positive surprises typically boost prices by 5-10%, while misses can cause 15-20% drops<\/li>\n<\/ul>\n<p>The October report will be particularly important as investors watch Leqembi&#8217;s commercial progress and how the company is managing declining sales from older MS drugs facing generic competition.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey: Rollercoaster with Recent Recovery<\/h2>\n<p>Biogen&#8217;s stock has been on quite the ride over the past six months:<\/p>\n<table>\n<thead>\n<tr>\n<th>Month<\/th>\n<th>Price Range<\/th>\n<th>Key Events<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>March 2025<\/td>\n<td>$153-160<\/td>\n<td>Starting strong but facing headwinds<\/td>\n<\/tr>\n<tr>\n<td>April 2025<\/td>\n<td>$142-150<\/td>\n<td>Generic competition concerns mounting<\/td>\n<\/tr>\n<tr>\n<td>May 2025<\/td>\n<td>$135-145<\/td>\n<td>Earnings beat but guidance cautious<\/td>\n<\/tr>\n<tr>\n<td>June 2025<\/td>\n<td>$128-138<\/td>\n<td>Clinical trial updates mixed<\/td>\n<\/tr>\n<tr>\n<td>July 2025<\/td>\n<td>$124-132<\/td>\n<td>Hit yearly lows around $124<\/td>\n<\/tr>\n<tr>\n<td>August 2025<\/td>\n<td>$135-142<\/td>\n<td>FDA approval boost +6%, current $139.12<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Why the volatility?<\/strong> Biogen operates in the notoriously unpredictable biotech sector where a single clinical trial result or FDA decision can move the stock 20-30% in a day. The recent recovery from July lows suggests investors are becoming more optimistic about the company&#8217;s pipeline.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current analyst consensus and pipeline potential:<\/p>\n<p><strong>2025 Year-End<\/strong>: $160-180 range (15-30% upside from current)<\/p>\n<ul>\n<li>Driven by Leqembi adoption and pipeline progress<\/li>\n<li><strong>Verdict: BUY<\/strong> &#8211; current undervaluation presents opportunity<\/li>\n<\/ul>\n<p><strong>2026 Forecast<\/strong>: $190-220<\/p>\n<ul>\n<li>Full-year Leqembi contribution expected<\/li>\n<li>New pipeline candidates advancing<\/li>\n<\/ul>\n<p><strong>2028 Projection<\/strong>: $250-300<\/p>\n<ul>\n<li>Multiple new product launches anticipated<\/li>\n<li>Market leadership in neurology strengthened<\/li>\n<\/ul>\n<p><strong>2030 Vision<\/strong>: $350-450<\/p>\n<ul>\n<li>Potential breakthrough Alzheimer&#8217;s treatments<\/li>\n<li>Expanded global market presence<\/li>\n<\/ul>\n<p>The wide range reflects the binary nature of biotech investing &#8211; success depends heavily on clinical trial outcomes and regulatory approvals.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>Clinical trial failures<\/strong>: A single failed Phase 3 trial could drop the stock 30-40%<\/li>\n<li><strong>Regulatory hurdles<\/strong>: FDA rejections or delays can devastate share price<\/li>\n<li><strong>Generic competition<\/strong>: Older MS drugs continue facing pressure (<a href=\"https:\/\/www.nasdaq.com\/articles\/biogen-gears-report-q2-earnings-heres-what-expect\">Tysabri biosimilars expected Q4 2025<\/a>)<\/li>\n<li><strong>Pricing pressures<\/strong>: Healthcare reform could impact drug pricing<\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li><strong>FDA approval momentum<\/strong>: Recent 6% jump shows regulatory success<\/li>\n<li><strong>Strong financials<\/strong>: $2.27 billion free cash flow, 13.85% return on equity<\/li>\n<li><strong>Pipeline progress<\/strong>: Phase 3 studies advancing across multiple indications<\/li>\n<li><strong>Undervaluation<\/strong>: Trading at 24% discount to analyst targets according to <a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-biib\/biogen\/news\/evaluating-biogens-prospects-after-recent-fda-approval-boost\">Simply Wall St analysis<\/a><\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start small<\/strong>: Allocate no more than 5% of your portfolio to high-volatility biotech stocks<\/li>\n<li><strong>Dollar-cost average<\/strong>: Buy in increments rather than all at once to reduce timing risk<\/li>\n<li><strong>Set price alerts<\/strong>: Monitor around earnings dates (next: October 29, 2025)<\/li>\n<li><strong>Diversify<\/strong>: Balance BIIB with more stable healthcare stocks<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Trading Biogen is like being in a relationship with a brilliant scientist &#8211; incredibly rewarding when things go right, but prepare for some dramatic mood swings when experiments don&#8217;t work out!&#8221;<\/p>\n<h2>\u2705 How to Buy Biogen Inc. (BIIB) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NASDAQ-listed stocks and reasonable fees<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Open and fund your account<\/td>\n<td>Start with an amount you&#8217;re comfortable potentially losing<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Research BIIB thoroughly<\/td>\n<td>Understand the risks and opportunities specific to biotech<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Place a limit order<\/td>\n<td>Set your maximum purchase price to avoid overpaying<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Monitor and set alerts<\/td>\n<td>Track earnings dates and clinical trial announcements<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2>\n<p>For those looking to start their investment journey, Pocket Option offers several advantages:<\/p>\n<ul>\n<li><strong>Minimum deposit: $5<\/strong> &#8211; Perfect for testing strategies with minimal risk<\/li>\n<li><strong>1-minute KYC verification<\/strong> &#8211; Upload any ID document and start trading immediately<\/li>\n<li><strong>100+ withdrawal methods<\/strong> &#8211; Flexibility with crypto, e-wallets, and traditional banking<\/li>\n<\/ul>\n<p>The platform&#8217;s low barrier to entry makes it ideal for beginners who want to gain experience with biotech stocks like Biogen without committing large amounts of capital initially.<\/p>\n<h2>\ud83c\udf0d Biogen in 2025: Neuroscience Innovation Leader<\/h2>\n<p>Biogen remains a dominant force in neurological research, focusing on devastating conditions like Alzheimer&#8217;s, multiple sclerosis, and ALS. The company&#8217;s <a href=\"https:\/\/www.biogen.com\/company.html\">business model<\/a> balances groundbreaking science with commercial execution, investing over $10 billion in manufacturing capabilities since 1995.<\/p>\n<p>Recent developments include a <strong>$2 billion investment<\/strong> in their Research Triangle Park facility to expand antisense oligonucleotide capabilities and modernize manufacturing through AI and automation. The company also entered a strategic collaboration with City Therapeutics for RNA interference therapy development.<\/p>\n<p><strong>Interesting Fact for 2025<\/strong>: Biogen&#8217;s manufacturing facilities now use artificial intelligence to predict equipment maintenance needs before failures occur, reducing downtime by 40% and ensuring continuous supply of critical medications to patients worldwide.<\/p>\n"},"faq":[{"question":"Is now a good time to buy Biogen stock?","answer":"Many analysts believe BIIB is undervalued currently, trading at a discount to price targets. However, biotech stocks are inherently volatile, so dollar-cost averaging may be wiser than timing a single entry point."},{"question":"What's the biggest risk with investing in Biogen?","answer":"Clinical trial failures represent the largest risk. A failed Phase 3 trial could drop the stock 30-40% in a single day, as seen historically with other biotech companies."},{"question":"How does Biogen make money?","answer":"Primarily through sales of multiple sclerosis treatments (though facing generic pressure) and newer products like Leqembi for Alzheimer's. The company also generates revenue from partnerships and licensing agreements."},{"question":"What percentage of my portfolio should be in biotech stocks like BIIB?","answer":"Most financial advisors recommend limiting high-volatility biotech exposure to 5-10% of a diversified portfolio due to the sector's unpredictable nature."},{"question":"How often does Biogen pay dividends?","answer":"Biogen does pay dividends quarterly, but the yield is relatively modest compared to more established pharmaceutical companies. The focus is more on growth and pipeline development than income generation."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is now a good time to buy Biogen stock?","answer":"Many analysts believe BIIB is undervalued currently, trading at a discount to price targets. However, biotech stocks are inherently volatile, so dollar-cost averaging may be wiser than timing a single entry point."},{"question":"What's the biggest risk with investing in Biogen?","answer":"Clinical trial failures represent the largest risk. A failed Phase 3 trial could drop the stock 30-40% in a single day, as seen historically with other biotech companies."},{"question":"How does Biogen make money?","answer":"Primarily through sales of multiple sclerosis treatments (though facing generic pressure) and newer products like Leqembi for Alzheimer's. The company also generates revenue from partnerships and licensing agreements."},{"question":"What percentage of my portfolio should be in biotech stocks like BIIB?","answer":"Most financial advisors recommend limiting high-volatility biotech exposure to 5-10% of a diversified portfolio due to the sector's unpredictable nature."},{"question":"How often does Biogen pay dividends?","answer":"Biogen does pay dividends quarterly, but the yield is relatively modest compared to more established pharmaceutical companies. The focus is more on growth and pipeline development than income generation."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Biogen Inc. (BIIB) shares - Investment in Biogen Inc. (BIIB) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Biogen Inc. (BIIB) shares - Investment in Biogen Inc. (BIIB) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-22T11:43:34+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Biogen Inc. (BIIB) shares &#8211; Investment in Biogen Inc. (BIIB) stock\",\"datePublished\":\"2025-08-22T11:43:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/\",\"name\":\"How to buy Biogen Inc. (BIIB) shares - Investment in Biogen Inc. (BIIB) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-08-22T11:43:34+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Biogen Inc. (BIIB) shares &#8211; Investment in Biogen Inc. (BIIB) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Biogen Inc. (BIIB) shares - Investment in Biogen Inc. (BIIB) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Biogen Inc. (BIIB) shares - Investment in Biogen Inc. (BIIB) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-22T11:43:34+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Biogen Inc. (BIIB) shares &#8211; Investment in Biogen Inc. (BIIB) stock","datePublished":"2025-08-22T11:43:34+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/","name":"How to buy Biogen Inc. (BIIB) shares - Investment in Biogen Inc. (BIIB) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-08-22T11:43:34+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biogen-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Biogen Inc. (BIIB) shares &#8211; Investment in Biogen Inc. (BIIB) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":343423,"slug":"how-to-buy-biogen-2","post_title":"Comment acheter des actions Biogen Inc. (BIIB) - Investir dans les actions Biogen Inc. (BIIB)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-biogen-2\/"},"it_IT":{"locale":"it_IT","id":343424,"slug":"how-to-buy-biogen-2","post_title":"Come acquistare azioni Biogen Inc. (BIIB) - Investire in azioni Biogen Inc. (BIIB)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-biogen-2\/"},"pl_PL":{"locale":"pl_PL","id":343422,"slug":"how-to-buy-biogen-2","post_title":"Jak kupi\u0107 akcje Biogen Inc. (BIIB) - Inwestycja w akcje Biogen Inc. (BIIB)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-biogen-2\/"},"es_ES":{"locale":"es_ES","id":343426,"slug":"how-to-buy-biogen-2","post_title":"C\u00f3mo comprar acciones de Biogen Inc. (BIIB) - Inversi\u00f3n en acciones de Biogen Inc. (BIIB)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-biogen-2\/"},"th_TH":{"locale":"th_TH","id":343427,"slug":"how-to-buy-biogen-2","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Biogen Inc. (BIIB) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Biogen Inc. (BIIB)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-biogen-2\/"},"tr_TR":{"locale":"tr_TR","id":343428,"slug":"how-to-buy-biogen-2","post_title":"Biogen Inc. (BIIB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biogen Inc. (BIIB) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biogen-2\/"},"vt_VT":{"locale":"vt_VT","id":343429,"slug":"how-to-buy-biogen-2","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Biogen Inc. (BIIB) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Biogen Inc. (BIIB)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biogen-2\/"},"pt_AA":{"locale":"pt_AA","id":343425,"slug":"how-to-buy-biogen-2","post_title":"Como comprar a\u00e7\u00f5es da Biogen Inc. (BIIB) - Investimento em a\u00e7\u00f5es da Biogen Inc. (BIIB)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-biogen-2\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/343275","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=343275"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/343275\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=343275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=343275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=343275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}